What is it about?
Studies safety of glucocorticoid replacement.
Featured Image
Why is it important?
It is a prospective trial over 5 years in patients with Addison's disease
Perspectives
The prospective nature of the trial give unique inforation of the long-term safety of replacement therapy in patients with Addison's disease.
Professor Gudmundur Johannsson
University of Gotheburg
Read the Original
This page is a summary of: Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study, European Journal of Endocrinology, March 2017, Bioscientifica,
DOI: 10.1530/eje-17-0067.
You can read the full text:
Contributors
The following have contributed to this page
